Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
Boudreaux
Kelly J
KJ
Vanderbilt University Medical Center, Nashville, TN 37232, USA. kelly.boudreaux@vanderbilt.edu
Chang
Sam S
SS
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal